Table 4. Total costs (US$) expended in each scheme (N = 10,732).
| Annual FIT scheme (N = 5,863) | Colonoscopy scheme (N = 4,869) | |
|---|---|---|
| 1st year FIT | 296,660 | — |
| 2nd year FIT | 225,986 | — |
| 3rd year FIT | 183,841 | — |
| 4th year FIT | 68,728 | — |
| Subtotal | US$775,215 (52.7%) | — |
| Consultation fee + Colonoscopy | 379,296 | 4,433,875 |
| Polypectomy | 39,304 | 358,124 |
| Bleeding | 31,555 | 113,560 |
| Perforation | 0 | 10,856 |
| Subtotal | US$450,154 (30.6%) | US$4,916,415 (95.1%) |
| Treatment for CRC Stage 1 | 87,410 | 166,540 |
| Treatment for CRC Stage 2 | 52,446 | 33,308 |
| Treatment for CRC Stage 3 | 28,856 | 54,978 |
| Treatment for CRC Stage 4 | 5,782 | 0 |
| Subtotal | US$,244,494 (16.6%) | US$254,826 (4.9%) |
| Total | US$1,469,863 (100%) | US$5,171,241 (100%) |
FIT: Faecal Immunochemical Tests; CRC: Colorectal Cancer.